NRIM vs BCAL

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 11, 2026

NRIM

61.8
AI Score
VS
NRIM Wins

BCAL

51.5
AI Score

Investment Advisor Scores

NRIM

62score
Recommendation
BUY

BCAL

52score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric NRIM BCAL Winner
Net Income 20.00M 28.09M BCAL
ROE 9.7% 4.8% NRIM
ROA 1.3% 0.7% NRIM
Total Assets 1.50B 4.03B BCAL
Cash 77.54M 264.95M BCAL
Debt/Equity 0.20 0.06 BCAL
Free Cash Flow 21.64M 22.60M BCAL

Relative Price Performance (Last 90 Days)

NRIM 1M: -3.3% · 3M: +2.1% BCAL 1M: +0.1% · 3M: +10.1%

Current Technical Phase

NRIM

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope 0.2%) with fading momentum, RSI 48

RSI (14): 48.0 · Price: $26.05

BCAL

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.0% over 20 days), RSI 58

RSI (14): 58.2 · Price: $21.82

Fundamentals Snapshot

Metric NRIM BCAL
Market Cap
Forward P/E 9.4 11.8
Trailing P/E 8.6 11.8
Revenue (TTM)
Revenue Growth 0.1% 0.0%
Gross Margin 1.0% 1.0%
Operating Margin 0.4% 0.5%
EPS 3.04 1.82
Dividend Yield 0.01% 0.01%

Frequently Asked Questions

Based on our detailed analysis, NRIM is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.